Oxford Nanopore to Commercialize DNA Strand Sequencing this Year; Illumina not Involved | GenomeWeb

By Julia Karow

This article was originally published Feb.1.

Oxford Nanopore Technologies plans to commercialize its DNA strand sequencing technology this year, making it likely the first company to bring a nanopore sequencer to market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.